• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常血糖性糖尿病酮症酸中毒:病因、评估与管理

Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management.

作者信息

Long Brit, Lentz Skyler, Koyfman Alex, Gottlieb Michael

机构信息

Department of Emergency Medicine, Brooke Army Medical Center, 3841 Roger Brooke Dr, Fort Sam Houston, TX 78234, United States of America.

Division of Emergency Medicine, Department of Surgery, Larner College of Medicine, University of Vermont, Burlington, VT, United States of America.

出版信息

Am J Emerg Med. 2021 Jun;44:157-160. doi: 10.1016/j.ajem.2021.02.015. Epub 2021 Feb 16.

DOI:10.1016/j.ajem.2021.02.015
PMID:33626481
Abstract

INTRODUCTION

Diabetic ketoacidosis is an endocrine emergency. A subset of diabetic patients may present with relative euglycemia with acidosis, known as euglycemic diabetic ketoacidosis (EDKA), which is often misdiagnosed due to a serum glucose <250 mg/dL.

OBJECTIVE

This narrative review evaluates the pathogenesis, diagnosis, and management of EDKA for emergency clinicians.

DISCUSSION

EDKA is comprised of serum glucose <250 mg/dL with an anion gap metabolic acidosis and ketosis. It most commonly occurs in patients with a history of low glucose states such as starvation, chronic liver disease, pregnancy, infection, and alcohol use. Sodium-glucose cotransporter-2 (SGLT2) inhibitors, which result in increased urinary glucose excretion, are also associated with EDKA. The underlying pathophysiology involves insulin deficiency or resistance with glucagon release, poor glucose availability, ketone body production, and urinary glucose excretion. Patients typically present with nausea, vomiting, malaise, or fatigue. The physician must determine and treat the underlying etiology of EDKA. Laboratory assessment includes venous blood gas for serum pH, bicarbonate, and ketones. Management includes resuscitation with intravenous fluids, insulin, and glucose, with treatment of the underlying etiology.

CONCLUSIONS

Clinician knowledge of this condition can improve the evaluation and management of patients with EDKA.

摘要

引言

糖尿病酮症酸中毒是一种内分泌急症。一部分糖尿病患者可能表现为伴有酸中毒的相对正常血糖,即正常血糖性糖尿病酮症酸中毒(EDKA),由于血清葡萄糖<250mg/dL,这种情况常被误诊。

目的

本叙述性综述为急诊临床医生评估EDKA的发病机制、诊断和管理。

讨论

EDKA表现为血清葡萄糖<250mg/dL,伴有阴离子间隙代谢性酸中毒和酮症。它最常见于有低血糖状态病史的患者,如饥饿、慢性肝病、妊娠、感染和酗酒。导致尿葡萄糖排泄增加的钠-葡萄糖协同转运蛋白-2(SGLT2)抑制剂也与EDKA有关。潜在的病理生理学涉及胰岛素缺乏或抵抗伴胰高血糖素释放、葡萄糖供应不足、酮体生成和尿葡萄糖排泄。患者通常表现为恶心、呕吐、不适或疲劳。医生必须确定并治疗EDKA的潜在病因。实验室评估包括检测血清pH值、碳酸氢盐和酮体的静脉血气分析。管理措施包括用静脉输液、胰岛素和葡萄糖进行复苏,并治疗潜在病因。

结论

临床医生对这种情况的了解可以改善EDKA患者的评估和管理。

相似文献

1
Euglycemic diabetic ketoacidosis: Etiologies, evaluation, and management.正常血糖性糖尿病酮症酸中毒:病因、评估与管理
Am J Emerg Med. 2021 Jun;44:157-160. doi: 10.1016/j.ajem.2021.02.015. Epub 2021 Feb 16.
2
Euglycemic Diabetic Ketoacidosis: A Review.正常血糖性糖尿病酮症酸中毒:综述
Curr Diabetes Rev. 2017;13(3):315-321. doi: 10.2174/1573399812666160421121307.
3
Euglycemic diabetic ketoacidosis caused by dapagliflozin: A case report.达格列净所致正常血糖性糖尿病酮症酸中毒:一例报告
Medicine (Baltimore). 2018 Jun;97(25):e11056. doi: 10.1097/MD.0000000000011056.
4
Euglycemic diabetic ketoacidosis: a diagnostic and therapeutic dilemma.正常血糖性糖尿病酮症酸中毒:诊断与治疗难题
Endocrinol Diabetes Metab Case Rep. 2017 Sep 4;2017. doi: 10.1530/EDM-17-0081. eCollection 2017.
5
Challenges in the Diagnosis of Euglycemic Diabetic Ketoacidosis in a Patient With Multiple Sclerosis Taking a Sodium-Glucose Cotransporter 2 Inhibitor.一名正在服用钠-葡萄糖协同转运蛋白2抑制剂的多发性硬化症患者发生正常血糖性糖尿病酮症酸中毒的诊断挑战
J Emerg Med. 2019 Jul;57(1):e1-e3. doi: 10.1016/j.jemermed.2019.03.011. Epub 2019 Apr 23.
6
Intraoperative Diagnosis of Sodium-Glucose Cotransporter 2 Inhibitor-Associated Euglycemic Diabetic Ketoacidosis: A Case Report.钠-葡萄糖共转运蛋白 2 抑制剂相关的血糖正常糖尿病酮症酸中毒的术中诊断:一例报告。
A A Pract. 2021 Jan 14;15(1):e01380. doi: 10.1213/XAA.0000000000001380.
7
Euglycemic Diabetic Ketoacidosis with Elevated Acetone in a Patient Taking a Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor.一名服用钠-葡萄糖协同转运蛋白2(SGLT2)抑制剂的患者出现丙酮升高的正常血糖性糖尿病酮症酸中毒。
J Emerg Med. 2017 Feb;52(2):223-226. doi: 10.1016/j.jemermed.2016.07.082. Epub 2016 Oct 4.
8
An Unsuspected Case of Euglycemic Diabetic Ketoacidosis With Twists.一例伴有波折的隐匿性正常血糖性糖尿病酮症酸中毒病例。
Cureus. 2022 Apr 10;14(4):e24016. doi: 10.7759/cureus.24016. eCollection 2022 Apr.
9
Euglycemic diabetic ketoacidosis in the era of SGLT-2 inhibitors.SGLT-2 抑制剂时代的血糖正常的糖尿病酮症酸中毒。
BMJ Open Diabetes Res Care. 2023 Oct;11(5). doi: 10.1136/bmjdrc-2023-003666.
10
Euglycemic Diabetic Ketoacidosis and Sodium-Glucose Cotransporter-2 Inhibitors: A Focused Review of Pathophysiology, Risk Factors, and Triggers.正常血糖性糖尿病酮症酸中毒与钠-葡萄糖协同转运蛋白2抑制剂:病理生理学、危险因素及诱发因素的重点综述
Cureus. 2021 Mar 3;13(3):e13665. doi: 10.7759/cureus.13665.

引用本文的文献

1
Perioperative prevention of euglycaemic diabetic ketoacidosis in people living with type 2 diabetes established on sodium-glucose transport-2 inhibitors - a cross-site multi-cycle audit.对使用钠-葡萄糖协同转运蛋白2抑制剂治疗的2型糖尿病患者围手术期正常血糖性糖尿病酮症酸中毒的预防——一项跨机构多周期审计
Clin Med (Lond). 2025 Aug 12;25(5):100502. doi: 10.1016/j.clinme.2025.100502.
2
Euglycemic DKA in a DPP-4 inhibitor patient following traumatic brain injury: A complex ICU glucose management challenge.一名创伤性脑损伤后使用二肽基肽酶-4抑制剂的患者发生正常血糖性糖尿病酮症酸中毒:重症监护病房复杂的血糖管理挑战。
Medicine (Baltimore). 2025 Jul 25;104(30):e43562. doi: 10.1097/MD.0000000000043562.
3
Sodium-Glucose Cotransporter-2 Inhibitors and Euglycemic Diabetic Ketoacidosis: A Case Series of Three Post-surgical Patients.
钠-葡萄糖协同转运蛋白2抑制剂与正常血糖性糖尿病酮症酸中毒:三例外科手术后患者的病例系列
Cureus. 2025 May 23;17(5):e84665. doi: 10.7759/cureus.84665. eCollection 2025 May.
4
Euglycemic Diabetic Ketoacidosis With Sepsis and Acute Kidney Injury in Critically Ill Patients: A Case Series.危重症患者中伴有脓毒症和急性肾损伤的正常血糖性糖尿病酮症酸中毒:病例系列
Cureus. 2025 May 11;17(5):e83920. doi: 10.7759/cureus.83920. eCollection 2025 May.
5
[Effects of "new" antidiabetic drugs on management of anesthesia].["新型"抗糖尿病药物对麻醉管理的影响]
Anaesthesiologie. 2025 Mar 31. doi: 10.1007/s00101-025-01521-w.
6
Unveiling Gestational Diabetes: An Overview of Pathophysiology and Management.揭开妊娠期糖尿病的面纱:病理生理学与管理概述
Int J Mol Sci. 2025 Mar 5;26(5):2320. doi: 10.3390/ijms26052320.
7
The real-world safety profile of empagliflozin: a disproportionality analysis based on the FDA Adverse Event Reporting System (FAERS) database.恩格列净的真实世界安全性概况:基于美国食品药品监督管理局不良事件报告系统(FAERS)数据库的不成比例性分析。
BMC Pharmacol Toxicol. 2025 Feb 7;26(1):28. doi: 10.1186/s40360-025-00861-y.
8
SGLT-2 inhibitors and diabetic ketoacidosis.钠-葡萄糖协同转运蛋白2抑制剂与糖尿病酮症酸中毒
Intern Emerg Med. 2025 Mar;20(2):337-340. doi: 10.1007/s11739-025-03862-1. Epub 2025 Jan 27.
9
Lymphocyte-C-reactive protein ratio upon admission to predict disease progression and ICU admission in adult patients with diabetic ketoacidosis.入院时淋巴细胞与C反应蛋白比值预测成年糖尿病酮症酸中毒患者的疾病进展及入住重症监护病房情况
Sci Rep. 2025 Jan 23;15(1):3012. doi: 10.1038/s41598-024-84054-3.
10
Euglycemic diabetic ketoacidosis associated metabolic encephalopathy caused by dapagliflozin: a rare case report.达格列净所致正常血糖性糖尿病酮症酸中毒相关代谢性脑病:一例罕见病例报告
BMC Neurol. 2025 Jan 14;25(1):20. doi: 10.1186/s12883-025-04027-5.